#molecule

Collection of molecule news, found 49 news.

Resverlogix to Spin-out RVX Therapeutics Inc. to Shareholders

- Transaction Designed to Enhance Shareholder Value By Unlocking Value of the Epigenetics Platform- TSX Exchange ...

Virobay and LEO Pharma Initiate a Phase 1 Trial of VBY-891, a Compound Intended for Oral Treatment of Psoriasis

-     Virobay, Inc. and LEO Pharma A/S today announced that their collaboration on the development ...

Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis

-     Takeda Pharmaceutical Company Limited ("Takeda") today announced that a Marketing ...

LEO Pharma and 4SC Discovery Announce Exclusive Research and License Agreement

-     LEO Pharma A/S, a global pharmaceutical company specialising in dermatology, has entered into ...

CAS Registers 70 Millionth Substance Just 18 Months After Reaching 60 Millionth Milestone

- Chemical Abstracts Service [http://www.cas.org/ ] (CAS), the world's authority for chemical information, announced ...

Resverlogix Completes Enrollment In ASSURE Trial

- Resverlogix Corp. (TSX:RVX) today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial ...

Resverlogix's BET Protein Inhibitor RVX-208 Meets Primary Endpoint

Resverlogix Corp. (TSX: RVX) today announced that the BET protein inhibitor RVX-208 significantly increased HDL-C ...

Lonza and BioWa Sign License Agreements with FivePrime Therapeutics for Use of Their POTELLIGENT(R)

-     Five Prime Therapeutics, Inc. ("FivePrime") has entered into research and commercial ...

Berg Pharma presents at ASCO, poised to lead field in cancer metabolism

-     Berg Pharma, a Boston-based pharmaceutical company presented at the 2012 American Society of ...

Jubilant and Endo Pharmaceuticals Announce Successful Delivery of Early Milestones in Collaborative

-         Jubilant Biosys Ltd., a Bengaluru-based subsidiary of Jubilant Life ...

Intellect Neurosciences, Inc. to Present at BIO Asia International Conference

-     Intellect Neurosciences, Inc. (OTCPK: ILNS) announces that Dr. Daniel G. Chain, chairman and ...

Intellect Neurosciences Obtains Two New Patents in Japan for Its Alzheimer's Immunotherapy Programs

-         Intellect Neurosciences, Inc. (OTCBB: ILNS), a biopharmaceutical company ...

S1P1 Program Assets Generated by Epix Pharmaceuticals, Inc. and Amgen Will Be Offered for Sale

-    Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee for the Benefit of Creditors of Epix Pharmaceuticals, ...

European telescope detects oxygen in space

The European Space Agency`s Herschel telescope has found the first confirmed evidence of oxygen molecules in space, ...

Phadia First Company to Receive FDA Clearance of Recombinant Allergen Component Tests

-510(K) Clearance Covers 13 Molecular Allergen Components     Newly-available tests provide deepest ...